Citadel Advisors - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 21 filers reported holding AKARI THERAPEUTICS PLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q4 2022$7,569
-49.5%
15,446
+2.5%
0.00%
Q2 2022$15,000
-75.8%
15,064
-60.1%
0.00%
Q3 2021$62,000
-31.1%
37,770
-27.7%
0.00%
Q2 2021$90,000
+23.3%
52,265
+88.6%
0.00%
Q1 2021$73,000
+78.0%
27,712
+46.2%
0.00%
Q2 2020$41,00018,9570.00%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q2 2020
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 7,941,867$1,443,0371.26%
Omnia Family Wealth, LLC 782,372$142,1570.11%
NEA Management Company, LLC 452,167$82,1590.01%
Hikari Power Ltd 130,821$240.00%
Bryn Mawr Capital Management, LLC 100,000$18,1700.00%
GEODE CAPITAL MANAGEMENT, LLC 30,264$5,4950.00%
MILLENNIUM MANAGEMENT LLC 261,192$470.00%
Renaissance Technologies 283,550$520.00%
LPL Financial LLC 134,453$24,4300.00%
JPMORGAN CHASE & CO 237$00.00%
View complete list of AKARI THERAPEUTICS PLC shareholders